0001434647-26-000009
SEC filingZevra Therapeutics, Inc. issued a press release on March 9, 2026 regarding results of operations and financial condition. The filing also discloses an employment agreement effective March 9, 2026 with Justin Renz and an executive change on March 4, 2026.